Bloomberg Stock Movers

2026-05-01 · Hosted by — · Bloomberg / iHeartMedia

Executive Summary

Pre-market action focused on big oil earnings beats with Exxon Mobil and Chevron both topping estimates as the Iran War’s impact on balance sheets becomes visible — higher energy prices added $1.7B to Exxon’s quarter while war-related production outages cost $400M with 15% of global output still offline. Estee Lauder surged ~12% on plans to cut up to 3,000 more jobs (totaling 10,000) as it shifts to online sales. Moderna +8% on Q1 sales more than tripling year-over-year, fueled by international combo flu/COVID vaccine approvals.

Key Stories & Changes

1. Big Oil Q1 Earnings Beats

  • XOM: Exxon Mobil — +0.3% pre-market — EPS $1.16 vs. $0.96 est., profit dropped to 5-year low <$5B (incl. temp accounting charges); higher energy prices added $1.7B; war outages cost $400M; 15% of global output offline, Strait of Hormuz reopening timing uncertain

  • CVX: Chevron — +0.7% pre-market — EPS $1.45 vs. $0.90 est. (massive beat); had pre-warned of derivative losses on cargo; lost $1B in international refining due to lower margins, unfavorable accounting, higher transport

2. Estee Lauder (EL) — +12% on Restructuring

  • Cutting up to 3,000 more jobs, bringing total to 10,000 (from prior 7,000 target)

  • Cuts coming from department store staff as company shifts to online sales

  • Projects $200 million in savings

  • Lifted FY earnings guidance to ~$2.40/share

  • Q3 results: top and bottom line beat

  • Americas organic growth flat; international sales pushed total to +2%

3. Moderna (MRNA) — +8% on International Strength

  • Q1 sales more than tripled year-over-year, beat estimates

  • Beat fueled by deals outside the US

  • February: European regulators cleared combo flu/COVID shot for adults 50+

  • US faces pressure: FDA initially refused flu vaccine review then reversed

  • US decision deadline: August 5

1. Iran War Splitting Energy Sector Winners and Losers

Higher commodity prices are providing meaningful upstream lift (Exxon $1.7B contribution) but the war’s production outages and the 15% offline output figure mean the sector’s profit picture is more complicated than the headline price moves suggest. Refining margins remain pressured internationally, with Chevron’s international refining segment losing $1B.

2. Estee Lauder’s Cost Cuts Validate Direct-to-Consumer Pivot

The increase from 7,000 to 10,000 job cuts and shift away from department store staff is a deliberate channel migration to online — generating $200M in savings and supporting a guidance raise. Notable as a consumer-discretionary playbook reaction to slow growth (Americas flat).

3. International Strength as Pharma Growth Driver

Moderna’s strength is concentrated outside the US, with European combo vaccine approval driving the beat while US regulatory friction continues. This pattern reinforces that international markets are the swing factor for vaccine players in 2026. —-

Sentiment Analysis

Overall Market Sentiment: Constructive

Pre-market reactions modest but uniformly positive across the four covered names; energy beats well-anticipated given commodity tailwind.

Risk Factors Highlighted

Strait of Hormuz Closure Duration Unknown: Exxon’s CFO said they “don’t know how long the strait will be closed”; protracted closure compounds production outage costs

Refining Margin Pressure: Chevron lost $1B in international refining due to lower margins, unfavorable accounting, higher transportation costs

US Regulatory Friction for Moderna: FDA initial refusal of flu vaccine review (since reversed) signals ongoing administrative pressure

Estee Lauder Americas Demand Weakness: Organic growth flat in Americas — turnaround dependent on continued international strength

Energy Sector Profit Concentration: Despite price tailwinds, profits dropped to multi-year lows when accounting charges included

This episode was covered in today’s The Market Signal — 2026-05-01, a cross-source synthesis of multiple podcast reports.

Keep Reading